Similar articles for PMID: 22644996

Year	Number of Results
2002	1
2003	1
2005	4
2006	4
2007	6
2008	8
2009	13
2010	13
2011	13
2012	15
2013	10
2014	11
2015	5
2016	5
2017	10
2018	6
2019	2
2020	6
2021	6
2022	3
2023	1
2024	0

1

Change in platelet levels during radiotherapy with concurrent and adjuvant temozolomide for the treatment of glioblastoma: a novel prognostic factor for survival.

Williams M, Liu ZW, Woolf D, Hargreaves S, Michalarea V, Menashy R, Kooner I, Wilson E. Williams M, et al. J Cancer Res Clin Oncol. 2012 Oct;138(10):1683-8. doi: 10.1007/s00432-012-1243-x. Epub 2012 May 27. J Cancer Res Clin Oncol. 2012. PMID: 22644996

2

Prognostic significance of concomitant radiotherapy in newly diagnosed glioblastoma multiforme: a multivariate analysis of 116 patients.

Okumus NO, Gursel B, Meydan D, Ozdemir O, Odabas E, Gonullu G. Okumus NO, et al. Ann Saudi Med. 2012 May-Jun;32(3):250-5. doi: 10.5144/0256-4947.2012.250. Ann Saudi Med. 2012. PMID: 22588435 Free PMC article.

3

Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.

Birol Sarica F, Tufan K, Cekinmez M, Sen O, Cem Onal H, Mertsoylu H, Topkan E, Pehlivan B, Erdogan B, Nur Altinors M. Birol Sarica F, et al. J Neurosurg Sci. 2010 Mar;54(1):7-19. J Neurosurg Sci. 2010. PMID: 20436394

4

Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide.

Donato V, Papaleo A, Castrichino A, Banelli E, Giangaspero F, Salvati M, Delfini R. Donato V, et al. Tumori. 2007 May-Jun;93(3):248-56. doi: 10.1177/030089160709300304. Tumori. 2007. PMID: 17679459

5

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Stupp R, et al. Lancet Oncol. 2009 May;10(5):459-66. doi: 10.1016/S1470-2045(09)70025-7. Epub 2009 Mar 9. Lancet Oncol. 2009. PMID: 19269895 Clinical Trial.

6

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients.

Minniti G, De Sanctis V, Muni R, Filippone F, Bozzao A, Valeriani M, Osti MF, De Paula U, Lanzetta G, Tombolini V, Maurizi Enrici R. Minniti G, et al. J Neurooncol. 2008 May;88(1):97-103. doi: 10.1007/s11060-008-9538-0. Epub 2008 Feb 5. J Neurooncol. 2008. PMID: 18250965

7

Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis.

Erpolat OP, Akmansu M, Goksel F, Bora H, Yaman E, Büyükberber S. Erpolat OP, et al. Tumori. 2009 Mar-Apr;95(2):191-7. doi: 10.1177/030089160909500210. Tumori. 2009. PMID: 19579865

8

Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.

Jeon HJ, Kong DS, Park KB, Lee JI, Park K, Kim JH, Kim ST, Lim DH, Kim WS, Nam DH. Jeon HJ, et al. Clin Neurol Neurosurg. 2009 Oct;111(8):679-82. doi: 10.1016/j.clineuro.2009.06.013. Epub 2009 Jul 28. Clin Neurol Neurosurg. 2009. PMID: 19640635 Clinical Trial.

9

The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma.

Sher DJ, Henson JW, Avutu B, Hochberg FH, Batchelor TT, Martuza RL, Barker FG 2nd, Loeffler JS, Chakravarti A. Sher DJ, et al. J Neurooncol. 2008 May;88(1):43-50. doi: 10.1007/s11060-008-9530-8. Epub 2008 Jan 30. J Neurooncol. 2008. PMID: 18231723 Free PMC article.

10

Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma.

Minniti G, De Sanctis V, Muni R, Rasio D, Lanzetta G, Bozzao A, Osti MF, Salvati M, Valeriani M, Cantore GP, Maurizi Enrici R. Minniti G, et al. J Neurooncol. 2009 Jan;91(1):95-100. doi: 10.1007/s11060-008-9689-z. Epub 2008 Aug 29. J Neurooncol. 2009. PMID: 18758912 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

117 results

Results by year